Gainers
- Blue Water Vaccines, Inc. (NASDAQ:BWV) shares rose 38.3% to $1.62 in pre-market trading. Blue Water Vaccines recently appointed Frank Jaeger, seasoned commercial operations and business development executive, as Senior Vice President of Marketing and Business Development.
- MDxHealth SA (NASDAQ:MDXH) rose 23.3% to $4.44 in pre-market trading after the company said UnitedHealthcare will provide commercial coverage for the Genomic Prostate Score (GPS) test.
- Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) shares rose 22.8% to $4.46 in pre-market trading as the company announced plans to acquire Phase 2 program for 225Ac-PSMA I&T, a radiopharmaceutical targeting metastatic castrate resistant prostate cancer..
- Palantir Technologies Inc. (NYSE:PLTR) rose 17% to $8.90 in pre-market trading after the company reported better-than-expected fourth-quarter financial results. The company also issued first-quarter and FY23 guidance.
- GeoVax Labs, Inc. (NASDAQ:GOVX) rose 15.3% to $0.8999 in pre-market trading.
- China Pharma Holdings, Inc. (NYSE:CPHI) rose 13.1% to $0.1096 in pre-market trading after dropping 7% on Monday. China Pharma, during December, announced the launch of N95 medical protective mask.
- Soligenix, Inc. (NASDAQ:SNGX) shares rose 11.5% to $6.51 in pre-market trading. Soligenix recently announced a reverse stock split.
- ContextLogic Inc. (NASDAQ:WISH) rose 9.8% to $0.9650 in pre-market trading. ContextLogic shares jumped over 37% on Monday after Citron Research made bullish comments on the stock on Twitter.
- TMC the metals company Inc. (NASDAQ:TMC) rose 8.6% to $1.13 in pre-market trading after dropping around 5% on Monday. The company, during December, filed prospectus for offering of up to $30 million common shares.
- ContraFect Corporation (NASDAQ:CFRX) rose 8.4% to $0.0698 in pre-market trading after declining around 4% on Monday.
Losers
Now Read This: Coca-Cola, Marriott International And 3 Stocks To Watch Heading Into Tuesday
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
